Sign in
MOLN Stock Price, Chart, Stats & News
Molecular Partners AG
Save
Molecular Partners AG (MOLN) does not currently pay a dividend.
154.17M
Market cap
–
Current P/E
1.70x
Forward P/E
MOLN chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | -0.00% |
ROA | -60.38% |
ROE | -60.05% |
D/E | 0.05x |
Interest coverage ratio | -3229.22x |
MOLN valuation
P/E | – |
P/S | – |
P/B | 1.51x |
P/CF | -2.36x |
P/FCF | -2.33x |
P/OCF | -2.36x |
PEG | -0.02x |
EV multiple | -3.36x |
About
Molecular Partners AG operates as a clinical-stage biopharmaceutical company, specializing in the identification, advancement, and commercialization of innovative therapeutic proteins. The firm's pipeline includes a range of product candidates, many of which utilize its proprietary DARPin® technology. Key developments include Abicipar, a DARPin therapeutic in Phase III clinical trials for addressing neovascular wet age-related macular degeneration and diabetic macular edema.
Similar securities
Based on sector and market capitalization
Report issue